Fine‐needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions
Authors:
- Aasmund BernerABAasmund Berner
- Ben DavidsonBDBen Davidson
- Bjørn RisbergBRBjørn Risberg
- 19 November 2003
- journal article
- research article
- Published by Wiley in Diagnostic Cytopathology
- Vol. 29 (6) , 344-348
Abstract
Fine‐needle aspiration cytology (FNAC) is an established, highly accurate method for diagnosing breast lesions. However, in recent years there has been increased use of core biopsy (CB) in this setting. The aim of this study was to evaluate the accuracy of FNAC and compare the quality assessment parameters of FNAC and CB in palpable and nonpalpable breast lesions. Data regarding FNAC, CB, and excision biopsy (EB) diagnoses were retrieved from the archives of our department. A total of 4,367 FNAC samples from the years 1999–2001 was reviewed. Of these, corresponding histology results were available for 1,275 lesions, of which 1,248 were primary breast epithelial lesions (788 EB, 199 CB, 261 EB+CB). All cases were analyzed for sensitivity and specificity of FNAC. Cases with both FNAC and CB were compared and quality assessment parameters were calculated using the methodology detailed in the National Health Service Breast Screening Program guidelines. High specificity and sensitivity, as calculated for satisfactory specimens, were achieved with the use of both FNAC and CB. False‐positive and false‐negative diagnoses were seen in 7/404 (1.7%) and 45/635 (7.1%) of biopsy‐proven specimens sampled by FNAC. The corresponding values for CB were 0% and 5.7%, respectively. Inadequate sampling (15.1%) with use of FNAC was particularly seen in collagenous lesions and in submitted specimens sampled by physicians lacking experience with the FNAC procedure. FNAC is a valuable method, although moderately less sensitive than CB. CB is the preferred method for preoperative diagnosis when sampling FNAC provides scarce material and suspicion of a fibrotic and collagenous lesion such as lobular carcinoma and radial scar arises. FNAC is most accurate when experienced cytologists are available and when immediate assessment by professionals is performed for evaluation of material adequacy, so that additional aspirations can be done when needed. Diagn. Cytopathol. 2003;29:344–348.Keywords
This publication has 22 references indexed in Scilit:
- Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlationThe American Journal of Surgery, 2002
- Nonmalignant Lesions in Breast Core Needle BiopsiesAmerican Journal of Surgical Pathology, 2002
- Fine needle aspiration cytology in the work-up of mammographic and ultrasonographic findings in breast cancer screening: an attempt at differentiating in situ and invasive carcinomaCytopathology, 2002
- Fine needle aspiration cytology versus percutaneous biopsy of nonpalpable breast lesionsEuropean Journal of Radiology, 2002
- Immediate on-site interpretation of fine-needle aspiration smearsCancer, 2001
- Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trialCancer, 1998
- Can core needle biopsy replace fine-needle aspiration cytology in the diagnosis of palpable breast carcinoma: A comparative study of 124 womenCancer, 1996
- Unsatisfactory aspirates from fine‐needle aspiration biopsies: A reviewDiagnostic Cytopathology, 1995
- Guidelines for cytology procedures and reporting on fine needle aspirates of the breastCytopathology, 1994
- Aspiration Biopsy in Diagnosis of Palpable Lesions of the Breast: Critical review of 3 479 consecutive biopsiesActa Radiologica: Therapy, Physics, Biology, 1968